Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Ewa Stawowczyk"'
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Hyperkalemia (HK) is frequently present in chronic kidney disease (CKD). Risk factors for HK among CKD patients include comorbidities and renin–angiotensin–aldosterone system inhibitor (RAASi) treatment. Current standard of ca
Externí odkaz:
https://doaj.org/article/8d4d1d3f8b934fc3adf2b91b191b2778
Publikováno v:
Antibiotics, Vol 13, Iss 7, p 664 (2024)
Background: The aim of the study was to characterize the procedure of peripheral intravenous therapy (IT), including the characteristics of vascular access and related complications and qualitative and quantitative analyses of drug consumption. Mater
Externí odkaz:
https://doaj.org/article/11faf056022e4dcd9970fedd98cf80b2
Autor:
Márta Szegedi, Tamás Zelei, Francis Arickx, Anna Bucsics, Emanuelle Cohn-Zanchetta, Jurij Fürst, Maria Kamusheva, Pawel Kawalec, Guenka Petrova, Juraj Slaby, Ewa Stawowczyk, Milan Vocelka, Ingrid Zechmeister-Koss, Zoltán Kaló, Mária Judit Molnár
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-8 (2018)
Abstract Background Funding of orphan medicinal products (OMPs) is an increasing challenge in the European Union (EU). Objectives To identify the different methods for public funding of OMPs in order to map the availability for rare disease patients,
Externí odkaz:
https://doaj.org/article/a2f788acf7c7464e84e7030297f9dcfe
Autor:
Ewa Stawowczyk, Krzysztof Piotr Malinowski, Paweł Kawalec, Rafał Bobiński, Jacek Siwiec, Dimitra Panteli, Helene Eckhardt, Steven Simoens, Antònia Agusti, Marc Dooms, Andrzej Pilc
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Objective: To review the reimbursement recommendations issued by selected European health technology assessment agencies for orphan drugs and the reimbursement status of these drugs; to assess the relationship between the type of recommendation and r
Externí odkaz:
https://doaj.org/article/440618f808e04dfa9ef508702e733fe0
Autor:
Ewa Stawowczyk, Paweł Kawalec
Publikováno v:
Gastroenterology Review, Vol 12, Iss 2, Pp 90-97 (2017)
The aim of this systematic review was to collect and summarise all current data on the cost-effectiveness of biological treatment in ulcerative colitis. A literature search was conducted using the Medline, Embase, Centre for Reviews and Dissemination
Externí odkaz:
https://doaj.org/article/6d776a293f24401ba1fabd927723e48e
Publikováno v:
Gastroenterology Review, Vol 12, Iss 1, Pp 60-65 (2017)
Introduction : Ulcerative colitis (UC) require expensive, lifelong treatment, which generates huge direct costs and has a significant impact on the quality of life, especially in the active state of the disease. Aim : To assess the indirect costs, he
Externí odkaz:
https://doaj.org/article/e56f43a4631a4824af6bb0fcbba724bf
Autor:
Paweł Kawalec, Tomas Tesar, Lenka Vostalova, Pero Draganic, Manoela Manova, Alexandra Savova, Guenka Petrova, Zinta Rugaja, Agnes Männik, Christoph Sowada, Ewa Stawowczyk, Andras Harsanyi, Andras Inotai, Adina Turcu-Stiolica, Jolanta Gulbinovič, Andrzej Pilc
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
Objectives: The aim of this study was to review reimbursement environment as well as pricing and reimbursement requirements for drugs in selected Central and Eastern Europe (CEE) countries.Methods: A questionnaire-based survey was performed in the pe
Externí odkaz:
https://doaj.org/article/b0fa5d3837f14a2fbbb05e49a187068d
Autor:
Paweł Kawalec, Ewa Stawowczyk, Tomas Tesar, Jana Skoupa, Adina Turcu-Stiolica, Maria Dimitrova, Guenka I. Petrova, Zinta Rugaja, Agnes Männik, Andras Harsanyi, Pero Draganic
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
Objectives: The aim of this study was to review the requirements for the reimbursement of biosimilars and to compare the reimbursement status, market share, and reimbursement costs of biosimilars in selected Central and Eastern European (CEE) countri
Externí odkaz:
https://doaj.org/article/ce1342996d2647398a53000ed330f02b
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0160444 (2016)
The objective of this study was to assess the cost-effectiveness of induction and maintenance treatment up to 1 year of ulcerative colitis with golimumab/standard care and standard care alone in Poland.A Markov model was used to estimate the expected
Externí odkaz:
https://doaj.org/article/0a5183ee277644efbb8a322185e17007
Autor:
Michał Bryliński, Katarzyna Prymula, Wiktor Jurkowski, Marek Kochańczyk, Ewa Stawowczyk, Leszek Konieczny, Irena Roterman
Publikováno v:
PLoS Computational Biology, Vol 3, Iss 5, p e94 (2007)
A description of many biological processes requires knowledge of the 3-D structure of proteins and, in particular, the defined active site responsible for biological function. Many proteins, the genes of which have been identified as the result of hu
Externí odkaz:
https://doaj.org/article/250e784a8d3643b695135e3677922925